J&J, Tracon deal

Johnson & Johnson’s Janssen Pharmaceutica N.V. unit granted Tracon exclusive, worldwide development rights to TRC253 (formerly JNJ-63576253) and TRC694 (formerly JNJ-64290694). The pharma’s J&J Innovation-JJDC venture arm made

Read the full 282 word article

How to gain access

Continue reading with a
two-week free trial.